Wedbush Securities Equity Research Welcomes Veteran Consumer Analyst Gerald Pascarelli, CFA® as Senior Vice President, Equity Research, Beverages; Initiates Coverage on CELH, KDP, MNST, PEP, KO, SAM, BFB, STZ, MGPI, TAP, and NAPA

LOS ANGELES–(BUSINESS WIRE)–Wedbush Securities, one of the nation’s leading independent diversified financial services providers, is pleased to announce the appointment of Gerald Pascarelli, CFA® as the newest Consumer Equity Research Analyst. Gerald initiates coverage on 11 stocks in a new sector for the firm, Beverages – Non-Alcoholic; Celsius Holdings, Inc. ... Read More

Rapid Dose Therapeutics Provides Update on Failure to File Cease Trade Order

BURLINGTON, Ontario–(BUSINESS WIRE)–Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, announces that further to its press release dated September 12, 2022, the Company and its auditors are continuing to work diligently to complete the audit of the Company’s annual ... Read More